Constellate Proteomics

See the future of your cell line in a single droplet

Constellate Proteomics is developing a compact device that aims to transform how protein-based drugs are analysed during development and production. By combining affinity probes with their patented single-molecule microscopy approach, the team is working toward a solution that allows for fast, sensitive analysis using only small sample volumes—without the need for large, expensive equipment or specialised operators.

The platform is designed with modularity in mind: its cartridge-based setup will eventually allow researchers to swap in different probe sets for new applications, such as disease diagnostics or academic research. While still in development, this flexibility positions Constellate for broader future use beyond drug development.

Team
Carlos de Lannoy
Dennis de Beeld
Arian Khoshchin
Startup activities

Venture Challenge Fall 2025

Contact
Carlos de Lannoy
carlos@constellate.pro